Cargando…
Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models
The global incidence of diabetes mellitus (DM) is increasing. Types 1 and 2 DM are associated with declining β-cell function. Verapamil (50% S-verapamil and 50% R-verapamil) can treat DM by downregulating thioredoxin-interacting protein (TXNIP), which induces islet β-cell apoptosis. However, it may...
Autores principales: | Chen, Yu-Syuan, Weng, Shao-Ju, Chang, Shu-Hsien, Li, Rou-Ying, Shane, Guang-Tzuu, Hsu, Jui-Pao, Yeh, Sheng-Wen, Chang, Ai-Ching, Lee, Meng-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345870/ https://www.ncbi.nlm.nih.gov/pubmed/34358247 http://dx.doi.org/10.1371/journal.pone.0255405 |
Ejemplares similares
-
A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes
por: Wang, Chih-Yuan, et al.
Publicado: (2022) -
Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
por: Cheng, Chih-Ning, et al.
Publicado: (2020) -
Effect of verapamil on bone mass, microstructure and mechanical properties in type 2 diabetes mellitus rats
por: Wu, Xiaodan, et al.
Publicado: (2022) -
Verapamil in Diabetes
por: Poudel, Resham Raj, et al.
Publicado: (2017) -
Association of Herpes Zoster and Type 1 Diabetes Mellitus
por: Chen, Hsin-Hung, et al.
Publicado: (2016)